BookmarkSubscribeRSS Feed
deleted_user
Not applicable
They are unique and very much needed in the pharmaceutical industry, I'd recommend people who work in the pharmaceutical/biotech industry to take the class.

Best Practices in SAS Statistical Programming for Regulatory Submission
http://guptaprogramming.com/pdf%20files/Brochure_SAS_Clinical_Programming.pdf

- Next on-line live class, April 22, 2008 at 11:00 a.m. - 12:30 p.m. (EST–New York time):

Best Practices in SAS Statistical Programming for Regulatory Submission: Understanding and Applying the QC Plan to Validate Summary Tables

(FIRST on-line course in a Two-Part Series) Limited seats, register now!
http://www.cfpa.com/200804222213-15a/2213/t/courseSummary.aspx


- Next on-line live class, May 20, 2008 at 11:00 a.m. - 12:30 p.m. (EST–New York time):

Best Practices in SAS Statistical Programming for Regulatory Submission: Creating Publication-Quality Summary Tables

(SECOND on-line course in a Two-Part Series) Limited seats, register now!
http://www.cfpa.com/200805202214-15a/2214/t/2214/0/CourseSearch.aspx
2 REPLIES 2
deleted_user
Not applicable
- Next on-line live class, May 20, 2008 at 11:00 a.m. - 12:30 p.m. (EST–New York time):

Best Practices in SAS Statistical Programming for Regulatory Submission: Creating Publication-Quality Summary Tables

(SECOND on-line course in a Two-Part Series) Limited seats, register now!
http://www.cfpa.com/200805202214-15a/2214/t/2214/0/CourseSearch.aspx
Doc_Duke
Rhodochrosite | Level 12
Your only posts have been for Gupta's classes. The forum is not for advertising.

hackathon24-white-horiz.png

2025 SAS Hackathon: There is still time!

Good news: We've extended SAS Hackathon registration until Sept. 12, so you still have time to be part of our biggest event yet – our five-year anniversary!

Register Now

Health and Life Sciences Learning

 

Need courses to help you with SAS Life Sciences Analytics Framework, SAS Health Cohort Builder, or other topics? Check out the Health and Life Sciences learning path for all of the offerings.

LEARN MORE

Discussion stats
  • 2 replies
  • 1324 views
  • 0 likes
  • 2 in conversation